Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update

被引：74
作者：
Borghi, Claudio [1 ]
Domienik-Karlowicz, Justyna [2 ,3 ]
Tykarski, Andrzej [4 ]
Widecka, Krystyna [5 ]
Filipiak, Krzysztof J. [6 ]
Jaguszewski, Milosz J. [7 ]
Narkiewicz, Krzysztof [8 ]
Mancia, Giuseppe [9 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] Med Univ Warsaw, Dept Internal Med & Cardiol, Ctr Diag & Treatment Venous Thromboembolism, Ul Lindleya 4, PL-00005 Warsaw, Poland
[3] Polish Cardiac Soc, Club 30, Warsaw, Poland
[4] Poznan Univ Med Sci, Dept Hypertens Angiol & Internal Dis, Poznan, Poland
[5] Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland
[6] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland
[7] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
[8] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[9] Univ Milano Bicocca, Milan, Italy
来源：
CARDIOLOGY JOURNAL | 2021年 / 28卷 / 01期
关键词：
SERUM URIC-ACID; URATE-LOWERING THERAPIES; INCIDENT HYPERTENSION; XANTHINE-OXIDASE; NATIONAL-HEALTH; HEART-FAILURE; GOUT; ALLOPURINOL; MORTALITY; DISEASE;
D O I：
10.5603/CJ.a2021.0001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 14
页数：14
相关论文
共 120 条
  • [1] GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    BRAND, FN
    KANNEL, WB
    CASTELLI, WP
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) : 237 - 242
  • [2] The causality between the serum uric acid level and stroke
    Ae, Ryusuke
    Kanbay, Mehmet
    Kuwabara, Masanari
    [J]. HYPERTENSION RESEARCH, 2020, 43 (04) : 354 - 356
  • [3] EFFECTS OF 2 DIPHOSPHONATES (EHDP AND CL2MDP) ON SERUM URIC-ACID IN PAGETIC PATIENTS
    ARLOT, ME
    MEUNIER, PJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1981, 33 (03) : 195 - 198
  • [4] Mutations in the SLC2A9 Gene Cause Hyperuricosuria and Hyperuricemia in the Dog
    Bannasch, Danika
    Safra, Noa
    Young, Amy
    Karmi, Nili
    Schaible, R. S.
    Ling, G. V.
    [J]. PLOS GENETICS, 2008, 4 (11)
  • [5] FAST: new look at the febuxostat safety profile
    Bardin, Thomas
    Richette, Pascal
    [J]. LANCET, 2020, 396 (10264) : 1704 - 1705
  • [6] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    Becker, MA
    Schumacher, HR
    Wortmann, RL
    MacDonald, PA
    Eustace, D
    Palo, WA
    Streit, J
    Joseph-Ridge, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2450 - 2461
  • [7] Mutations in the Mitochondrial Seryl-tRNA Synthetase Cause Hyperuricemia, Pulmonary Hypertension, Renal Failure in Infancy and Alkalosis, HUPRA Syndrome
    Belostotsky, Ruth
    Ben-Shalom, Efrat
    Rinat, Choni
    Becker-Cohen, Rachel
    Feinstein, Sofia
    Zeligson, Sharon
    Segel, Reeval
    Elpeleg, Orly
    Nassar, Suheir
    Frishberg, Yaacov
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2011, 88 (02) : 193 - 200
  • [8] Genetic factors associated with gout and hyperuricemia
    Bleyer, AJ
    Hart, TC
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2006, 13 (02) : 124 - 130
  • [9] Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
    Bobulescu, Alexandru
    Moe, Orson W.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2012, 19 (06) : 358 - 371
  • [10] Prognostic value of serumuric acid: new-onset in and out-of-office hypertension and long-termmortality
    Bombelli, Michele
    Ronchi, Irene
    Volpe, Marco
    Facchetti, Rita
    Carugo, Stefano
    Dell'Oro, Raffaella
    Cuspidi, Cesare
    Grassi, Guido
    Mancia, Giuseppe
    [J]. JOURNAL OF HYPERTENSION, 2014, 32 (06) : 1237 - 1244
12345678910